Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Unknown status (1)

Phase

n/a (1)

phase 1/phase 2 (1)

Sponsor

Spark Therapeutics (2)

CSL Behring (1)

University of Erlangen-Nurnberg Medical School (1)

Collaborator

Intervention

beriplex® p/n (1)

fresh frozen plasma (1)

fresh frozen plasma (ffp) and beriplex® p/n (1)

mass spectrometry (lc-ms/ms) (1)

spk-8016 (1)

standard of care fviii replacement therapy (1)

Study Documents

Intervention Type

biological (1)

diagnostic test (1)

drug (1)

genetic (1)

other (1)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (2)

Observational (2)

coagulation protein disorders

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Data of Current FVIII Prophylaxis Replacement Therapy in Adult

Active, not recruiting

Blood Coagulation Disorder
+8 more

Standard of Care FVIII Replacement therapy

San Francisco, California
+10 more

Feb 18, 2022

Adeno-Associated Virus (AAV), Blood Coagulation Disorder, Blood Coagulation Disorders, Inherited Trial in United States

Recruiting

Adeno-Associated Virus (AAV)
+16 more

SPK-8016

Los Angeles, California
+13 more

Feb 3, 2022

Preterm Birth, Coagulation Protein Disorders, Coagulation Disorder Neonatal Trial in Erlangen (mass spectrometry (LC-MS/MS))

Unknown status

Preterm Birth
+2 more

mass spectrometry (LC-MS/MS)

Erlangen, Bavaria, Germany

Department of Pediatrics- and Adolescent Medicine, FAU Erlangen-

Oct 23, 2019

Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)

Completed

Coagulation Protein Disorders
+2 more

Beriplex® P/N
+2 more

Blackburn, United Kingdom
+5 more

Oct 2, 2017